drugset / Trial / NCT00203801
Combination Antimalarials in Uncomplicated Malaria
Completed
700 enrolled
University of Cape Town
Global Fund · collabMedical Research Council, South Africa · collabWorld Health Organization · collab
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to study the efficacy of sulfadoxine-pyrimethamine on its own and compare this with efficacy of a new combination antimalarial therapy, either sulphadoxine-pyrimethamine plus artesunate or artemether-lumefantrine.
Timeline
- Start
- 2002-01
- Primary completion
- 2005-07
- Completion
- 2005-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Artemether-lumefantrine | Unknown | — | — |
| Subject | Artesunate | Small molecule | — | — |
| Subject | Sulfadoxine-pyrimethamine | Small molecule | — | — |